Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on April 16, 2025

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported that shareholders …

Male Enhancement Procedure by Upsize LLC Surpasses 1,000 Cases, Drives Rapid National Expansion

Male Enhancement Procedure by Upsize LLC Surpasses 1,000 Cases, Drives Rapid National Expansion

ROSEVILLE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Upsize LLC, an innovative provider of non-surgical male enhancement treatments, today announced it has successfully performed over 1,000 procedures nationwide, achieving significant growth in just two …

Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight

Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight

New York, USA, April 16, 2025 (GLOBE NEWSWIRE) -- Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight The in-vitro diagnostics market is projected to experience positive revenue growth due to factors such …

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

CHICAGO, April 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…

Arkos360® Care Management Platform Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance

Arkos360® Care Management Platform Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance

Gilbert, AZ, April 16, 2025 (GLOBE NEWSWIRE) -- In an era where digital threats continuously evolve and data breaches become increasingly common, ensuring the security and confidentiality of sensitive information holds paramount importance. At Arkos Health …

Dr. Sud Agarwal Leads iNGENu CRO in Launching Groundbreaking Clinical Trials for Sleep Disorders Following Ethics Approval

Dr. Sud Agarwal Leads iNGENu CRO in Launching Groundbreaking Clinical Trials for Sleep Disorders Following Ethics Approval

Melbourne, Australia, April 16, 2025 (GLOBE NEWSWIRE) -- iNGENū CRO, a specialist Contract Research Organization with deep expertise in the complex field of sleep medicine, is pleased to announce that two clinical trials targeting rare and debilitating …

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

Saint-Herblain (France), April 16, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its presence at the forthcoming 25th World Vaccine Congress, which will take place from April 21-24, 2025 at the Walter E …

Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress dont une présentation sur son vaccin contre le chikungunya IXCHIQ®

Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress dont une présentation sur son vaccin contre le chikungunya IXCHIQ®

Saint-Herblain (France), le 16 avril 2025 - Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui sa présence au 25ème World Vaccine Congress, qui se tiendra du 21 au 24 avril 2025 au Walter E. …

First Steroid Cycle: Beginner’s Guide to Bulking & Cutting + (Before And After Result ) - 2025 - By CrazyBulk in USA

First Steroid Cycle: Beginner’s Guide to Bulking & Cutting + (Before And After Result ) - 2025 - By CrazyBulk in USA

New York City, April 16, 2025 (GLOBE NEWSWIRE) -- As long as a beginner wants to achieve huge increases in muscle mass size and bulk, starting a cycle of steroids can be very effective. This article provides a comprehensive look at everything one must know …

Olon Receives 2025 CMO Excellence in Green Chemistry Award

Olon Receives 2025 CMO Excellence in Green Chemistry Award

RODANO, Italy, April 16, 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. is honored to announce its receipt of the esteemed 2025 CMO Excellence in Green Chemistry Award. This accolade, conferred by the ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS …

PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES

PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES

MINNEAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine and …

Closest Things to Steroids 2025: Safe & Legal Substitute for Muscle Growth & Bodybuilding - Legal Alternatives By CrazyBulk USA

Closest Things to Steroids 2025: Safe & Legal Substitute for Muscle Growth & Bodybuilding - Legal Alternatives By CrazyBulk USA

Albany, New York, April 16, 2025 (GLOBE NEWSWIRE) -- If you are under the pressure of losing weight and building lean muscle, legal steroid alternatives become a savior for you. They will offer you the same amount of muscle gain like you would have done …

Sabin Begins Marburg Vaccine Trial in U.S.

Sabin Begins Marburg Vaccine Trial in U.S.

WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial …

Best Oral Steroids 2025 - Bodybuilding Steroids for Muscle Growth, Strength & Huge Size - Bodybuilders' #1 Picks - By CrazyBulk USA

Best Oral Steroids 2025 - Bodybuilding Steroids for Muscle Growth, Strength & Huge Size - Bodybuilders' #1 Picks - By CrazyBulk USA

Albany, New York, April 16, 2025 (GLOBE NEWSWIRE) --  Oral anabolic steroids, or oral steroids, are artificial medications that are similar in action to the male sex hormone testosterone. Oral steroids are useful while bulking, gaining strength, and other …

Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment

Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment

SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …

Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023 

Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023 

AGOURA HILLS, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications, including Parkinson's Disease, pancreatic ductal …

Sonnet Releases Virtual Investor "What This Means" Segment

Sonnet Releases Virtual Investor "What This Means" Segment

- Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010 - Watch the "What This Means" video here PRINCETON, N.J., April 16, 2025 (GLOBE NEWSWIRE) …

Biomerica Announces Reverse Stock Split

Biomerica Announces Reverse Stock Split

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, today announced that it will implement a 1-for-8 reverse stock split of the issued and outstanding shares of …

NeuroOne® Issues Letter to Shareholders

NeuroOne® Issues Letter to Shareholders

Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a …

Doheny Eye Institute Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting

Doheny Eye Institute Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting

PASADENA, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that more than 25 of its scientists and clinician-scientists will present their latest research at the upcoming …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service